The use of SNP-array has assisted adding new information to molecular mechanism, that is, the discovery of important gene mutations of MDS, for example, mutations of proto-oncogene CBL, TET2 and JARID2 [[3], [4], [5]]. This evidence concerns the gene TET2 and myelodysplastic syndrome.